Iterum Therapeutics plc
ITRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $35 | $26 | $10 | $64 |
| - Cash | $24 | $6 | $21 | $27 |
| + Debt | $46 | $19 | $30 | $30 |
| Enterprise Value | $56 | $38 | $19 | $67 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EBITDA | -$22 | -$35 | -$40 | -$83 |
| % Margin | – | – | – | – |
| Net Income | -$25 | -$38 | -$44 | -$92 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.26 | -2.96 | -3.63 | -8.41 |
| % Growth | 57.4% | 18.5% | 56.8% | – |
| Operating Cash Flow | -$27 | -$39 | -$18 | -$16 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$27 | -$39 | -$19 | -$16 |